{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:54:50Z","timestamp":1791003290868,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T00:00:00Z","timestamp":1267056000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Natural health products (NHPs), such as herbal medicines and vitamins, are widely available over-the-counter and are often purchased by consumers without advice from a healthcare provider. This study examined how consumers respond when they believe they have experienced NHP-related adverse drug reactions (ADRs) in order to determine how to improve current safety monitoring strategies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Qualitative semi-structured interviews were conducted with twelve consumers who had experienced a self-identified NHP-related ADR. Key emergent themes were identified and coded using content analysis techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Consumers were generally not comfortable enough with their conventional health care providers to discuss their NHP-related ADRs. Consumers reported being more comfortable discussing NHP-related ADRs with personnel from health food stores, friends or family with whom they had developed trusted relationships. No one reported their suspected ADR to Health Canada and most did not know this was possible.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Consumers generally did not report their suspected NHP-related ADRs to healthcare providers or to Health Canada. Passive reporting systems for collecting information on NHP-related ADRs cannot be effective if consumers who experience NHP-related ADRs do not report their experiences. Healthcare providers, health food store personnel, manufacturers and other stakeholders also need to take responsibility for reporting ADRs in order to improve current pharmacovigilance of NHPs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1472-6882-10-8","type":"journal-article","created":{"date-parts":[[2010,2,25]],"date-time":"2010-02-25T19:17:00Z","timestamp":1267125420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Consumers of natural health products: natural-born pharmacovigilantes?"],"prefix":"10.1186","volume":"10","author":[{"given":"Rishma","family":"Walji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zubin","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Ross","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,25]]},"reference":[{"key":"285_CR1","volume-title":"Baseline natural health products survey among consumers","author":"Natural Health Products Directorate","year":"2005","unstructured":"Natural Health Products Directorate: Baseline natural health products survey among consumers. 2005, Ipsos Reid; Health Canada"},{"key":"285_CR2","volume-title":"Natural health products regulations: SOR\/2003-196","author":"NHPD","year":"2003","unstructured":"NHPD: Natural health products regulations: SOR\/2003-196. 2003"},{"issue":"5","key":"285_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1046\/j.1365-2036.2003.01689.x","volume":"18","author":"MH Pittler","year":"2003","unstructured":"Pittler MH, Ernst E: Systematic review: hepatotoxic events associated with herbal medicines. Alimentary Pharmacology & Therapeutics. 2003, 18 (5): 451-471. 10.1046\/j.1365-2036.2003.01689.x.","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"285_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1440-1746.2008.05310.x","volume":"23","author":"S Chitturi","year":"2008","unstructured":"Chitturi S, Farrell G: Hepatotoxic slimming aids and other herbal hepatotoxins. Journal of gastroenterology and hepatology. 2008, 23 (3): 366-373. 10.1111\/j.1440-1746.2008.05310.x.","journal-title":"Journal of gastroenterology and hepatology"},{"key":"285_CR5","volume-title":"U.S. Department of Health and Human Services; Advance Data From Vital and Health Statistics","author":"Center for Disease Control","year":"2004","unstructured":"Center for Disease Control: Complementary and Alternative Medicine Use Among Adults: United States, 2002. U.S. Department of Health and Human Services; Advance Data From Vital and Health Statistics. 2004"},{"key":"285_CR6","volume-title":"Canadian Adverse Drug Reaction Monitoring Program (CADRMP) Adverse Reaction Database","author":"Canada Health","year":"2007","unstructured":"Canada Health: Canadian Adverse Drug Reaction Monitoring Program (CADRMP) Adverse Reaction Database. 2007"},{"key":"285_CR7","first-page":"345","volume-title":"Stephens' Detection of New Adverse Drug Reactions","author":"P Waller","year":"2004","unstructured":"Waller P, Tilson H: Managing drug safety issues with marketed products. Stephens' Detection of New Adverse Drug Reactions. Edited by: Talbot J, Waller P. 2004, Chicester: Wiley, 345-374. 5","edition":"5"},{"issue":"12","key":"285_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2165\/00002018-200326120-00001","volume":"26","author":"J Barnes","year":"2003","unstructured":"Barnes J: Pharmacovigilance of herbal medicines: a UK perspective. Drug Safety. 2003, 26 (12): 829-851. 10.2165\/00002018-200326120-00001.","journal-title":"Drug Safety"},{"key":"285_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.pec.2006.07.007","volume":"65","author":"E Murray","year":"2007","unstructured":"Murray E, Pollack L, White M, Lo B: Clinical decision-making: Patients' preferences and experiences. Patient Education and Counseling. 2007, 65: 189-196. 10.1016\/j.pec.2006.07.007.","journal-title":"Patient Education and Counseling"},{"issue":"1","key":"285_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13698570601183033","volume":"9","author":"A Alaszewski","year":"2007","unstructured":"Alaszewski A, Brown P: Risk, uncertainty and knowledge. Health, Risk and Society. 2007, 9 (1): 1-10. 10.1080\/13698570601183033.","journal-title":"Health, Risk and Society"},{"issue":"3","key":"285_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0277-9536(96)00353-X","volume":"45","author":"D Lupton","year":"1997","unstructured":"Lupton D: Consumerism, reflexivity and the medical encounter. Social Science & Medicine. 1997, 45 (3): 373-381. 10.1016\/S0277-9536(96)00353-X.","journal-title":"Social Science & Medicine"},{"key":"285_CR12","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1046\/j.1365-2125.1998.00715.x","volume":"45","author":"J Barnes","year":"1998","unstructured":"Barnes J, Mills SY, Abbot NC, Willoughby M, Ernst E: Different standards for reporting ADRs to herbal remedies and OTC medicines: face-to-face interviews with 515 users of herbal remedies. British Journal of Clinical Pharmacology. 1998, 45: 496-500. 10.1046\/j.1365-2125.1998.00715.x.","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"7","key":"285_CR13","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1345\/aph.1H463","volume":"41","author":"TL Charrois","year":"2007","unstructured":"Charrois TL, Hill RL, Vu D, Foster BC, Boon HS, Cramer K, Vohra S: Community identification of natural health product-drug interactions. The Annals of Pharmacotherapy. 2007, 41 (7): 1124-1129. 10.1345\/aph.1H463.","journal-title":"The Annals of Pharmacotherapy"},{"key":"285_CR14","volume-title":"Qualitative Inquiry and Research Design: Chosing Among Five Traditions","author":"J Creswell","year":"1998","unstructured":"Creswell J: Qualitative Inquiry and Research Design: Chosing Among Five Traditions. 1998, London: Sage"},{"key":"285_CR15","first-page":"851","volume-title":"Handbook of Qualitative Research","author":"E Chambers","year":"2000","unstructured":"Chambers E: Applied Ethnography. Handbook of Qualitative Research. Edited by: Denzin N, Lincoln Y. 2000, Thousand Oaks: Sage, 851-869. 2","edition":"2"},{"key":"285_CR16","volume-title":"NVivo 2.0 [Software for Qualitative Research]","author":"L Richards","year":"2002","unstructured":"Richards L, Richards T: NVivo 2.0 [Software for Qualitative Research]. 2002, Melbourne: QSR Solutions"},{"key":"285_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L: How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006, 18: 59-82. 10.1177\/1525822X05279903.","journal-title":"Field Methods"},{"issue":"1","key":"285_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2008.04.019","volume":"20","author":"HS Rehan","year":"2009","unstructured":"Rehan HS, Chopra D, Kakkar AK: Physician's guide to pharmacovigilance: terminology and causality assessment. European Journal of Internal Medicine. 2009, 20 (1): 3-8. 10.1016\/j.ejim.2008.04.019.","journal-title":"European Journal of Internal Medicine"},{"issue":"1","key":"285_CR19","doi-asserted-by":"crossref","first-page":"323S","DOI":"10.1093\/ajcn\/85.1.323S","volume":"85","author":"JJ Woo","year":"2007","unstructured":"Woo JJ: Adverse event monitoring and multivitamin-multimineral dietary supplements. American Journal of Clinical Nutrition. 2007, 85 (1): 323S-324S.","journal-title":"American Journal of Clinical Nutrition"},{"issue":"6","key":"285_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1517\/14740338.6.6.705","volume":"6","author":"IW Hammond","year":"2007","unstructured":"Hammond IW, Rich DS, Gibbs TG: Effect of consumer reporting on signal detection: using disproportionality analysis. Expert Opinion on Drug Safety. 2007, 6 (6): 705-712. 10.1517\/14740338.6.6.705.","journal-title":"Expert Opinion on Drug Safety"},{"issue":"9","key":"285_CR21","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/S0277-9536(98)00213-5","volume":"47","author":"B Williams","year":"1998","unstructured":"Williams B, Coyle J, Healy D: The meaning of patient satisfaction with health care: an exploration of high reported levels. Social Science & Medicine. 1998, 47 (9): 1351-1360. 10.1016\/S0277-9536(98)00213-5.","journal-title":"Social Science & Medicine"},{"issue":"October","key":"285_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2307\/1251973","volume":"63","author":"LL Price","year":"1999","unstructured":"Price LL, Arnould EJ: Commercial friendships: Service provider-client relationships in context. Journal of Marketing. 1999, 63 (October): 38-56. 10.2307\/1251973.","journal-title":"Journal of Marketing"},{"issue":"1","key":"285_CR23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1592\/phco.23.1.64.31912","volume":"23","author":"JK Glisson","year":"2003","unstructured":"Glisson JK, Rogers HE, Abourashed EA, Ogletree R, Hufford CD, Khan I: Clinic at the health food store? Employee recommendations and product analysis. Pharmacotherapy. 2003, 23 (1): 64-72. 10.1592\/phco.23.1.64.31912.","journal-title":"Pharmacotherapy"},{"issue":"1161","key":"285_CR24","first-page":"U165","volume":"115","author":"B Healey","year":"2002","unstructured":"Healey B, Burgess C, Siebers R, Beasley R, Weatherall M, Holt S: Do natural health food stores require regulation?. New Zealand Medical Journal. 2002, 115 (1161): U165-","journal-title":"New Zealand Medical Journal"},{"issue":"4","key":"285_CR25","first-page":"77","volume":"4","author":"R Walji","year":"2009","unstructured":"Walji R, Boon H, Barnes J, Austin Z, Baker GR, Welsh S: Adverse event reporting for herbal medicines: A result of market forces. Healthcare Policy. 2009, 4 (4): 77-90.","journal-title":"Healthcare Policy"},{"issue":"6","key":"285_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s002280050498","volume":"54","author":"A Alvarez-Requejo","year":"1998","unstructured":"Alvarez-Requejo A, Carvajal A, Begaud B, Moride Y, Vega T, Arias L: Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and sentinel system. European Journal of Clinical Pharmacology. 1998, 54 (6): 483-488. 10.1007\/s002280050498.","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"11","key":"285_CR27","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1503\/cmaj.1040498","volume":"170","author":"GR Baker","year":"2004","unstructured":"Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, Etchells E, Ghali WA, Hebert P, Muajumdar SR, O'Beirne M, Palacios-Derflingher L, Reid RJ, Sheps S, Tamblyn R: The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. Canadian Medical Association Journal. 2004, 170 (11): 1678-1685. 10.1503\/cmaj.1040498.","journal-title":"Canadian Medical Association Journal"},{"issue":"5","key":"285_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW: Under-reporting of adverse drug reactions: A systematic review. Drug Safety. 2006, 29 (5): 385-396. 10.2165\/00002018-200629050-00003.","journal-title":"Drug Safety"},{"issue":"6478","key":"285_CR29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1136\/bmj.290.6478.1355","volume":"290","author":"WH Inman","year":"1985","unstructured":"Inman WH: Under-reporting of adverse drug reactions. British Medical Journal. 1985, 290 (6478): 1355-10.1136\/bmj.290.6478.1355.","journal-title":"British Medical Journal"},{"issue":"2","key":"285_CR30","first-page":"39","volume":"16","author":"J Park","year":"2005","unstructured":"Park J: Use of alternative health care. Health Reports. 2005, 16 (2): 39-","journal-title":"Health Reports"},{"key":"285_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/pon.552","volume":"11","author":"K Tasaki","year":"2002","unstructured":"Tasaki K, Maskarinec G, Shumay D, Tatsumura Y, Kakai H: Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology. 2002, 11: 212-220. 10.1002\/pon.552.","journal-title":"Psychooncology"},{"issue":"s2","key":"285_CR32","doi-asserted-by":"crossref","first-page":"s88","DOI":"10.3747\/co.v15i0.282","volume":"15","author":"MJ Verhoef","year":"2008","unstructured":"Verhoef MJ, Boon HS, Page SA: Talking to cancer patients about complementary therapies: is it the physicians' responsibility?. Current Oncology. 2008, 15 (s2): s88-s93.","journal-title":"Current Oncology"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-10-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6882-10-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-10-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6882-10-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:45:51Z","timestamp":1630471551000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/1472-6882-10-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,25]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1186\/1472-6882-10-8","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,25]]},"assertion":[{"value":"30 November 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"8"}}